scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1056/NEJM198805053181805 |
P698 | PubMed publication ID | 3283548 |
P2093 | author name string | Peto R | |
Collins R | |||
Yusuf S | |||
Scrimgeour A | |||
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | thrombosis | Q261327 |
P304 | page(s) | 1162-1173 | |
P577 | publication date | 1988-05-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery | |
P478 | volume | 318 |
Q34707410 | A 56-year-old woman with early acute pulmonary emboli following pelvic reconstructive surgery |
Q37205453 | A National Analysis of Complications Following Total Hip Replacement in Patients With Chronic Obstructive Pulmonary Disease |
Q37876398 | A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery. |
Q33823987 | A clinical decision support system for venous thromboembolism prophylaxis at a general hospital in a middle-income country |
Q33489807 | A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery |
Q53925915 | A geriatric-anesthesiologic program to reduce acute confusional states in elderly patients treated for femoral neck fractures. |
Q46163394 | A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007). |
Q38268898 | A systematic review of contemporary trials of anticoagulants in orthopaedic thromboprophylaxis: suggestions for a radical reappraisal |
Q38065716 | Acute pulmonary embolectomy |
Q35667911 | Acute pulmonary embolism after pneumonectomy |
Q44877496 | Advances in bioresponsive closed-loop drug delivery systems |
Q35704525 | Anticoagulant drugs in the elderly: the risks usually outweight the benefits |
Q35704478 | Anticoagulant drugs in the elderly: valuable in selected patients |
Q24187310 | Anticoagulants for acute ischaemic stroke |
Q24240765 | Anticoagulants for acute ischaemic stroke |
Q24246662 | Anticoagulants for acute ischaemic stroke |
Q68436855 | Anticoagulants in the prevention of venous thromboembolism |
Q43942831 | Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin |
Q40647947 | Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration |
Q40647941 | Antiplatelet treatment for thromboprophylaxis: a step forward or backwards? |
Q38665558 | Antithrombotic therapy in acute myocardial infarction: prevention of venous, left ventricular and coronary artery thromboembolism |
Q35752541 | Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
Q33732426 | Archie Cochrane's challenge: can periodically updated reviews of all randomised controlled trials relevant to neurology and neurosurgery be produced? |
Q38572083 | Are Higher Hospital Venous Thromboembolism Rates an Indicator of Better Quality?: Evaluation of the Validity of a Hospital Quality Measure |
Q35174317 | Attitudes to the use of prophylaxis for thrombo-embolism in neurosurgical patients |
Q41117809 | Audit of attitudes to and use of postoperative thromboembolic prophylaxis in a regional health authority |
Q41247295 | Bemiparin for thromboprophylaxis after benign gynecologic surgery: a randomized clinical trial |
Q34428788 | Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis. |
Q68016405 | Benefits and risks of unfractionated heparin in general surgery |
Q37896527 | Bleeding and thromboembolic outcomes for patients on oral anticoagulation undergoing elective colon and rectal abdominal operations |
Q44417557 | Bleeding peptic ulcer occurring in hospitalized patients: analysis of predictive and risk factors and comparison with out-of-hospital onset of hemorrhage |
Q77325989 | Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism? |
Q67541320 | Can the hierarchy in techniques for the prevention of thromboembolism in visceral surgery be determined? |
Q53177363 | Catastrophic pulmonary and paradoxical embolism. |
Q70790802 | Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet |
Q28193059 | Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New Zealand |
Q33392773 | Choosing the Right Heparin Prophylaxis Strategy in Medical Patients at Risk for Developing VTE: An Evidence-Based Approach |
Q41115235 | Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials |
Q37608455 | Clinical efficacy and safety of fondaparinux in the prevention and treatment of venous and arterial thrombosis |
Q35159132 | Clinical experience of melagatran/ximelagatran in major orthopaedic surgery |
Q47834411 | Clinical overview of venous thromboembolism |
Q33384243 | Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacement |
Q37019860 | Clinical use of parnaparin in major and minor orthopedic surgery: a review |
Q39169740 | Coagulation and fibrinolysis during lung surgery:an experimental study. |
Q52330360 | Coarse-grained molecular dynamics simulations of fibrin polymerization: effects of thrombin concentration on fibrin clot structure. |
Q72114851 | Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration |
Q86717254 | Comparative effectiveness in head and neck malignancies |
Q36232265 | Comparison of 3,000 and 5,000 IU aXa/day certoparin in the prevention of deep-vein thrombosis after total hip replacement. |
Q91660927 | Complications of Retroperitoneal Lymph Node Dissection |
Q34178716 | Complications of laparoscopy |
Q48319318 | Complications of subcutaneous low-dose heparin therapy in neurosurgical patients |
Q33495687 | Contemporary use of and future roles for heparin in antithrombotic therapy |
Q33576223 | Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism |
Q33543587 | Current concepts of coagulation and fibrinolysis |
Q33492588 | Current trends in the development of anticoagulant and antithrombotic drugs. |
Q28194897 | DVT prophylaxis and anticoagulation in the surgical patient |
Q72726091 | DVT prophylaxis in total hip replacement |
Q41139783 | Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders |
Q37215274 | Deep Venous Thrombosis in the Surgical Intensive Care Unit |
Q81584045 | Deep vein thrombosis |
Q40582653 | Deep vein thrombosis of the lower limbs: diagnosis and management |
Q41671908 | Deep vein thrombosis prophylaxis protocol--needs active enforcement |
Q34144439 | Deep vein thrombosis: a clinical review |
Q72158143 | Deep vein thrombosis: prevention in stroke patients during rehabilitation |
Q77748222 | Deep venous thrombosis and pulmonary embolism in bilateral lower-extremity amputee patients |
Q37503130 | Deep venous thrombosis and pulmonary embolism. |
Q33650840 | Defining incidence and risk factors of venous thromboemolism after hepatectomy. |
Q68166937 | Dermatan sulphate: A safe approach to prevention of postoperative deep vein thrombosis |
Q36657982 | Development and validation of a predictive model for chemotherapy-associated thrombosis |
Q35122966 | Diagnosis and treatment of pulmonary embolism in the elderly |
Q34078303 | Diet as prophylaxis and treatment for venous thromboembolism? |
Q37216645 | Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients |
Q35594629 | Do anticoagulants improve survival in patients presenting with venous thromboembolism? |
Q33415859 | Do postliver transplant patients need thromboprophylactic anticoagulation? |
Q36156937 | Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty |
Q94150613 | Early postoperative mortality after 67,548 total hip replacements: causes of death and thromboprophylaxis in 68 hospitals in Norway from 1987 to 1999 |
Q77137707 | Economic evaluation of the use of nadroparin calcium in the prophylaxis of deep vein thrombosis and pulmonary embolism in surgical patients in Italy |
Q34552291 | Effect of inpatient quality of care on functional outcomes in patients with hip fracture |
Q34560241 | Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials |
Q43845104 | Effect of labor on maternal dehydration, starvation, coagulation, and fibrinolysis |
Q73254160 | Effect of tourniquet use on blood loss and incidence of deep vein thrombosis in total knee arthroplasty |
Q35711442 | Effects of fibrinolytic inhibitors on mortality from upper gastrointestinal haemorrhage |
Q34343613 | Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial |
Q51106636 | Efficacy of deep venous thrombosis prophylaxis in the medical intensive care unit. |
Q92276338 | Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients |
Q40541289 | Enoxaparin. A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease |
Q37806818 | Epidemiology and Incidence: The Scope of the Problem and Risk Factors for Development of Venous Thromboembolism |
Q33501811 | Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology |
Q34264218 | Epidemiology, risk factors and sequelae of venous thromboembolism |
Q35739440 | Estimating anesthesia time using the medicare claim: a validation study |
Q35101097 | Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux). |
Q35570059 | Evidence‐based guidelines for fixing broken hips: an update |
Q38605635 | Extended Pharmacologic Thromboprophylaxis in Oncologic Liver Surgery is Safe and Effective |
Q34959822 | Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol |
Q33805098 | Extracts from "clinical evidence": hip fracture |
Q26750983 | Failure to rescue patients from early critical complications of oesophagogastric cancer surgery |
Q37210283 | Fatal pulmonary embolism in hospitalised medical patients |
Q88801668 | Fibrin polymerization simulation using a reactive dissipative particle dynamics method |
Q49167887 | Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison |
Q34515387 | Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial |
Q40868152 | Future research needs for venous thrombo-embolic disease in obstetrics and gynaecology |
Q95799893 | Generalisations on benefits of aspirin are dangerous |
Q77905389 | Global statement on deep venous thrombosis prophylaxis during laparoscopic surgery.SAGES position statement. Society of American Gastrointestinal Endoscopic Surgeons |
Q35150857 | Glycosaminoglycans in Prophylaxis Against Venous Thromboembolism |
Q34432531 | Graduated compression stockings in hip fractures |
Q33719115 | Graduated compression stockings in the prevention of venous thromboembolism |
Q50185648 | Hemodynamic, respiratory, and metabolic effects of laparoscopic cholecystectomy |
Q47263066 | Heparin and low molecular weight heparin decrease nitric oxide production by human polymorphonuclear cells |
Q24194750 | Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction) |
Q24239862 | Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction) |
Q24240104 | Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction) |
Q67567501 | Heparin in the treatment of deep venous thrombosis |
Q43713377 | Heparin, deep venous thrombosis, and trauma patients |
Q38264844 | Heparin-based treatment to prevent symptomatic deep venous thrombosis, pulmonary embolism or death in general medical inpatients is not supported by best evidence |
Q24247417 | Heparins and mechanical methods for thromboprophylaxis in colorectal surgery |
Q58486041 | Hip fracture |
Q71200405 | Hirudin CGP 39393 as thromboprophylaxis |
Q50732455 | Identification of DVT diseases using numerical simulations. |
Q37877058 | Identification of patient venous thromboembolism risk across the continuum of care |
Q51068566 | Incidence of postoperative deep vein thrombosis after robotic-assisted laparoscopic prostatectomy: a prospective study in Chinese patients. |
Q51555062 | Incidence of pulmonary thromboembolism in gastric cancer surgery using routine thromboprophylaxis. |
Q68016390 | Incidence of thromboembolism depending on the type of surgery |
Q38212499 | Incidence of venous thromboembolism following major surgery in Korea: from the Health Insurance Review and Assessment Service database. |
Q80079335 | Increased Factor V Leiden frequency is associated with venous thrombotic events among young Brazilian patients |
Q73979679 | Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach |
Q42977224 | Interferon as treatment for acute hepatitis C. A meta-analysis |
Q36821233 | Investigation of suspected lower limb venous thrombosis |
Q45329950 | Is development of postoperative venous thromboembolism related to thromboprophylaxis use? A case-control study in the Veterans Health Administration |
Q38117180 | Is extended thromboprophylaxis necessary in elective colorectal cancer surgery? |
Q92120681 | Is pharmacological anticoagulant prophylaxis necessary for adolescent idiopathic scoliosis surgery? |
Q41597142 | Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement? |
Q98181513 | Is venous thromboembolism a preventable cause of death? |
Q28318920 | Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis |
Q41182598 | Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) |
Q67494547 | Low molecular weight heparin in general and gynecologic surgery |
Q34534567 | Low molecular weight heparin in prevention of perioperative thrombosis |
Q33499141 | Low molecular weight heparin(oid)s. Clinical investigations and practical recommendations |
Q35233595 | Low molecular weight heparins. An objective overview |
Q40832171 | Low molecular weight heparins: current use and indications |
Q33569506 | Low molecular weight versus unfractionated heparin. A clinical and economic appraisal |
Q47292625 | Low-molecular-weight heparin and partial thromboplastin time-adjusted unfractionated heparin in thromboprophylaxis after total knee and total hip arthroplasty |
Q33332833 | Low-molecular-weight heparin for thrombophilia in pregnant women |
Q77919968 | Low-molecular-weight heparins |
Q42804922 | Massive pulmonary embolus in a 14 year old boy. |
Q40238877 | Mechanical and pharmacological methods to prevent venous thromboembolism |
Q45152223 | Medical complications in total laryngectomy: incidence and risk factors |
Q47206731 | Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery |
Q34423980 | Meta-analysis of randomized trials comparing combined compression and anticoagulation with either modality alone for prevention of venous thromboembolism after surgery |
Q68349525 | Modern treatment of pulmonary embolism |
Q34485192 | Monitoring for suspected pulmonary embolism. |
Q35080331 | Monitoring of low molecular weight heparin in pregnancy |
Q100940709 | Mortality benefits of thromboprophylaxis |
Q100940711 | Mortality benefits of thromboprophylaxis - Authors' reply |
Q34346122 | Multicentre hospital drug utilization study on the prophylaxis of venous thromboembolism. The Venous Thromboembolism Study Group of the Spanish Society of Clinical Pharmacology |
Q54509886 | Nationwide practice patterns for the use of venous thromboembolism prophylaxis among men undergoing radical prostatectomy. |
Q90743518 | Necessity of the Periodical Ultrasound Assessment of the Peripheral Venous System in Intensive Care Unit Patients |
Q47338881 | New Therapeutic Opportunities for Heparins: What Does Low Molecular Weight Heparin Offer? |
Q41593809 | New frontiers in the management of unstable coronary artery disease |
Q34072627 | New therapeutic options in deep vein thrombosis prophylaxis. |
Q34893606 | Oral heparin: status review |
Q47097136 | Orthopaedic surgeons and thromboprophylaxis. |
Q47126033 | Orthopaedic surgeons and thromboprophylaxis. |
Q55419744 | Orthopaedic surgeons and thromboprophylaxis. |
Q38095148 | Overview and assessment of risk factors for pulmonary embolism |
Q43051829 | PREOP: development of an evidence-based expert system to assist with preoperative assessments |
Q33487898 | Parnaparin. A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders |
Q34264223 | Pathways for venous thromboembolic prophylaxis in medical and surgical patients |
Q70504771 | Peri-operative heparin: a possible adjuvant to surgery in colo-rectal cancer? |
Q34283927 | Peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery |
Q38573932 | Perioperative Management of Antithrombotic Therapy in Common Otolaryngologic Surgical Procedures: State of the Art Review |
Q40916978 | Perioperative care of the elderly patient |
Q48426976 | Perioperative deep vein thrombosis in Chinese patients undergoing craniotomy |
Q46630338 | Perioperative management of patients on oral anticoagulants: a decision analysis |
Q34211162 | Perioperative pharmacologic prophylaxis for venous thromboembolism in colorectal surgery |
Q38611801 | Perioperative risk assessment. Common misconceptions |
Q38915679 | Perioperative risk factors for death among patients with symptomatic pulmonary thromboembolism |
Q31127779 | Pharmacologic Thromboprophylaxis in Obstetrics: Broader Use Demands Better Data |
Q37568164 | Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins |
Q34474103 | Physical examination findings in deep venous thrombosis |
Q71968632 | Physical prevention of thrombosis with the ankle joint with the motorized ankle joint movement device. Initial results of a clinical study |
Q40627711 | Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients |
Q64967555 | Plasma microparticles are not elevated in fresh plasma from patients with gynaecological malignancy--an observational study. |
Q50531670 | Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks? |
Q63753999 | Postoperative fatal pulmonary embolism in a general surgical department |
Q44017888 | Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison |
Q36307908 | Postoperative nadroparin administration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after spinal surgery |
Q40594545 | Postsurgical complications in older patients. The role of pharmacological intervention. |
Q33678527 | Practice parameters for the management of colonic cancer I: surgical issues. Recommendations of the Colorectal Surgical Society of Australia. |
Q73681279 | Practices in the Prevention of Venous Thromboembolism |
Q37669093 | Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients |
Q44071706 | Predictors of mortality after acute hip fracture |
Q39471557 | Prevalence of venous thromboembolism risk factors and prophylactic adequacy among general surgical patients in a tertiary care hospital |
Q37681486 | Prevention and treatment of thromboembolic events in medical patients and new anticoagulants |
Q33496843 | Prevention and treatment of venous thromboembolism |
Q24632902 | Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
Q24632872 | Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines |
Q33370626 | Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin |
Q67844218 | Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group |
Q45016452 | Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393. |
Q37165360 | Prevention of hospital-acquired thrombosis from a primary care perspective: a qualitative study |
Q40639985 | Prevention of postoperative venous thromboembolism following laparoscopic cholecystectomy |
Q40641987 | Prevention of postoperative venous thromboembolism: an update |
Q57943255 | Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial |
Q67541323 | Prevention of thromboembolism in gynecology |
Q73433630 | Prevention of venous thromboembolism |
Q35229348 | Prevention of venous thromboembolism after surgery: A review of enoxaparin |
Q33359976 | Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors |
Q44606092 | Prevention of venous thromboembolism in North America: results of a survey among general surgeons. |
Q35513368 | Prevention of venous thromboembolism in Wales: results of a survey among general surgeons |
Q35031645 | Prevention of venous thromboembolism in acute medical illness |
Q33636726 | Prevention of venous thromboembolism in general surgery |
Q39021399 | Prevention of venous thromboembolism in gynecologic oncology surgery |
Q37393398 | Prevention of venous thromboembolism in hospitalized patients with cancer |
Q53371904 | Prevention of venous thromboembolism in patients admitted to Australian hospitals: summary of National Health and Medical Research Council clinical practice guideline. |
Q35581095 | Prevention of venous thromboembolism in spinal surgery |
Q71551072 | Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies) |
Q58861106 | Prevenção do tromboembolismo na cirurgia do câncer do aparelho digestivo |
Q37316796 | Primary prevention of venous thromboembolism in elderly medical patients |
Q24187077 | Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery |
Q24203816 | Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery |
Q36822755 | Primary total hip replacement: variations in patient management in Oxford & Anglia, Trent, Yorkshire & Northern 'regions'. |
Q34059375 | Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism |
Q33919309 | Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis |
Q51628283 | Prophylactic vena cava filter insertion in patients with traumatic spinal cord injury: preliminary results. |
Q37944582 | Prophylaxis for deep vein thrombosis and pulmonary embolism in the geriatric patient undergoing surgery. |
Q37939894 | Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient. |
Q35537469 | Prophylaxis in elective colorectal surgery: the cost of ignoring the evidence |
Q48887406 | Prophylaxis of Venous Thrombosis |
Q74729697 | Prophylaxis of deep venous thrombosis and pulmonary embolism. Current recommendations |
Q37827836 | Prophylaxis of venous thromboembolism |
Q40522514 | Prophylaxis of venous thromboembolism in brain tumor patients |
Q47366990 | Prospective randomized clinical study in general surgery comparing a new low molecular weight heparin with unfractionated heparin in the prevention of thrombosis |
Q36821253 | Protocol violation in deep vein thrombosis prophylaxis |
Q79954098 | Pulmonary embolism |
Q67554800 | Pulmonary embolism in surgical practice |
Q34196135 | Pulmonary embolism in the elderly |
Q68004018 | Pulmonary embolism in the elderly |
Q33334475 | Pulmonary embolus after coronary artery bypass surgery: a review of the literature. |
Q71628839 | Pulmonary scintigraphy at the bedside in intensive care patients with suspected pulmonary embolism |
Q54297862 | Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan. |
Q54118938 | Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group. |
Q33348161 | Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy |
Q77306749 | Rational antithrombotic therapy and prophylaxis in elderly, immobile patients |
Q37180937 | Rationale for development of low-molecular-weight heparins and their clinical potential in the prevention of postoperative venous thrombosis |
Q80646999 | Re: Venous thromboembolism prophylaxis: is two better than one? |
Q57313187 | Recent advances in cerebrovascular disease |
Q36080543 | Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis |
Q44261964 | Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the U |
Q39877727 | Risk factors and prophylaxis for venous thromboembolism in hospitals in the city of Manaus, Brazil |
Q50944058 | Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis. |
Q35747987 | Risk factors for inpatient venous thromboembolism despite thromboprophylaxis |
Q47760186 | Risk of Venous Thromboembolism Among Otolaryngology Patients vs General Surgery and Plastic Surgery Patients |
Q67479995 | Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group |
Q36120976 | Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients |
Q77742224 | Risk reduction in the intensive care unit |
Q28212759 | Risk-based evaluation of thromboprophylaxis among surgical inpatients: are low risk patients treated unnecessarily? |
Q28316082 | Risk-benefit assessment of anticoagulant therapy |
Q51446008 | Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy. |
Q72614020 | Safety of preoperative enoxaparin in head and neck cancer surgery |
Q52251926 | Screening for asymptomatic deep vein thrombosis in surgical intensive care patients. |
Q50775335 | Seasonal variation in occurrence of pulmonary embolism: analysis of the database of the Emilia-Romagna region, Italy. |
Q35160253 | Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery |
Q33394876 | Side-effects of antithrombotic therapy |
Q36790943 | Some limits to evidence-based medicine: a case study from elective orthopaedics |
Q39004019 | Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty |
Q38053889 | Statins for the prevention of venous thromboembolism? a narrative review |
Q59075880 | Statistics of chronic disease control |
Q37961826 | Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies |
Q45922621 | Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis. |
Q28354097 | Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial |
Q41121444 | Surgical debate. We still have insufficient evidence to support perioperative heparin prophylaxis against venous thromboembolism |
Q34989818 | Surgical treatment of colon and rectal cancer. |
Q35056481 | Survey of pharmacologic thromboprophylaxis in critically ill children |
Q28088683 | Systematic review with meta-analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitis |
Q37232098 | The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force |
Q97542590 | The Pathway to Low Outlier Status in Venous Thromboembolism Events: An Analysis of Pancreatic Surgery in the National Surgical Quality Improvement Program |
Q40543054 | The Prevention of Venous Thromboembolism in Surgical Patients |
Q42560177 | The aspirin papers |
Q47349893 | The defined daily doses of low molecular weight heparins do not reflect current clinical practice |
Q33698200 | The effect of a continuing medical education program on Venous thromboembolism prophylaxis utilization and mortality in a tertiary-care hospital |
Q54593707 | The effect of new oral anticoagulants and extended thromboprophylaxis policy on hip and knee arthroplasty outcomes: observational study. |
Q41938437 | The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty |
Q37179099 | The impact of inherited thrombophilia on surgery: a factor to consider before transplantation? |
Q38568574 | The natural history and epidemiology of venous thrombosis |
Q40487628 | The pathogenesis and prevention of thromboembolic complications in patients undergoing total hip replacement |
Q40752692 | The pathophysiology of venous thrombosis |
Q35656148 | The pulmonary physician and critical care. 5. Management of pulmonary embolism |
Q41355836 | The risk of thromboembolism in patients undergoing colorectal surgery. |
Q36259760 | The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests |
Q37117062 | The use of antiembolic stockings. Part 1: a literature review |
Q67976890 | The use of thromboprophylaxis in total hip replacement surgery: are the attitudes of orthopaedic surgeons changing? |
Q34648639 | Therapeutic equivalency of low-molecular-weight heparins |
Q44868404 | Thrombin-Responsive Transcutaneous Patch for Auto-Anticoagulant Regulation |
Q55484259 | Thromboembolic phenomena in neurosurgical patients operated upon for primary and metastatic brain tumours |
Q26825670 | Thromboembolism prevention in surgery of digestive cancer |
Q37213750 | Thromboembolism prophylaxis. Choosing the proper method for surgical patients |
Q40912552 | Thrombolysis for life-threatening pulmonary embolism 2 days after lung resection |
Q35081863 | Thromboprophylaxis and thrombosis in medical, surgical, trauma, and obstetric/gynecologic patients |
Q42785688 | Thromboprophylaxis for adults in hospital |
Q33915936 | Thrombosis risk in the trauma patient. Prevention and treatment |
Q42281396 | Thrombotic risk assessment questionary helps increase the use of thromboprophylaxis for patients with pelvic and acetabular fractures |
Q50530432 | Timing of preoperative pharmacoprophylaxis for pancreatic surgery patients: a venous thromboembolism reduction initiative. |
Q73052586 | Tolerability, pharmacokinetics, and pharmacodynamics of DX-9065a, a new synthetic potent anticoagulant and specific factor Xa inhibitor, in healthy male volunteers |
Q36937149 | Tonsillectomy in the anticoagulated patient |
Q38730070 | Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children |
Q34047349 | Treatment of hypertension with renin-angiotensin system inhibitors and renal dysfunction: a systematic review and meta-analysis. |
Q46210022 | Trials of antiplatelet therapy: Authors' reply |
Q41355828 | Unresolved issues in the prevention of venous thromboembolism. |
Q40880210 | Update. Deep vein thrombosis and pulmonary embolism prophylaxis in orthopedic surgery. |
Q36821944 | Use of a thromboembolic risk score to improve thromboprophylaxis in surgical patients |
Q24802144 | Use of venous thromboprophylaxis and adherence to guideline recommendations: a cross-sectional study |
Q34791576 | Usefulness of the computed tomography venography for evaluation of leg edema including deep vein thrombosis in rehabilitation patients |
Q53430758 | Variation in Hospital Thromboprophylaxis Practices for Abdominal Cancer Surgery. |
Q43154529 | Variation in physician deep vein thrombosis prophylaxis attitudes and practices at an academic tertiary care center |
Q33970367 | Vascular drugs in the new millennium |
Q57211198 | Venous Thromboembolism Incidence and Prophylaxis Use After Gastrectomy Among Korean Patients With Gastric Adenocarcinoma: The PROTECTOR Randomized Clinical Trial |
Q38613357 | Venous Thromboembolism Prophylaxis in Liver Surgery |
Q40559027 | Venous Thromboembolism Prophylaxis in a South Australian Teaching Hospital |
Q35815447 | Venous Thromboembolism-Incidence of Deep Venous Thrombosis and Pulmonary Embolism in Patients with Head and Neck Cancer: A Tertiary Care Experience in Pakistan |
Q71574398 | Venous hemodynamics during impulse foot pumping |
Q40836864 | Venous thromboembolic complications in children |
Q33935332 | Venous thromboembolic complications in obstetrics and gynecology with a focus on the role of low molecular weight heparin |
Q37427823 | Venous thromboembolic disease in colorectal patients |
Q55214497 | Venous thromboembolic disease in uncemented total hip replacement surgery--a one-year follow-up of 490 patients. |
Q33415676 | Venous thromboembolic prophylaxis after a hepatic resection: patterns of care among liver surgeons |
Q77712999 | Venous thromboembolic prophylaxis for transurethral prostatectomy: practice among British urologists |
Q41256710 | Venous thromboembolism (VTE) prophylaxis and urological pelvic cancer surgery: a UK national audit |
Q36330566 | Venous thromboembolism (VTE) risk assessment and prophylaxis in acute orthopaedic admissions: improving compliance with national guidelines |
Q48559598 | Venous thromboembolism after hepatic resection: analysis of 5,706 patients |
Q45034330 | Venous thromboembolism after major urologic oncology surgery: a focus on the incidence and timing of thromboembolic events after 27,455 operations. |
Q37566749 | Venous thromboembolism after oral and maxillofacial oncologic surgery: Report and analysis of 14 cases in Chinese population. |
Q33906746 | Venous thromboembolism after surgery for benign prostatic hyperplasia |
Q34342941 | Venous thromboembolism and cancer: prevention of VTE. |
Q44355973 | Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study |
Q90399293 | Venous thromboembolism in head and neck surgery: Risk, outcome, and burden at the national level |
Q37137952 | Venous thromboembolism in hospitalised patients: a public health crisis? |
Q35103066 | Venous thromboembolism in intensive care patients |
Q38117302 | Venous thromboembolism in otolaryngology surgical inpatients receiving chemoprophylaxis |
Q26797444 | Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis |
Q33673802 | Venous thromboembolism in the intensive care unit |
Q73280080 | Venous thromboembolism in the intensive care unit |
Q40617575 | Venous thromboembolism in trauma patients |
Q84974214 | Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment |
Q36797819 | Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review |
Q39457080 | Venous thromboembolism prophylaxis in urology: A review |
Q89684331 | Venous thromboembolism rates after hip and knee arthroplasty and hip fractures |
Q37197643 | Venous thromboembolism: A problem in the Indian/Asian population? |
Q81829757 | Venous thromboembolism: an ounce of prevention |
Q34351113 | Venous thrombosis and anticoagulant therapy |
Q40559351 | Venous thrombosis: prevention, treatment, and relationship to paradoxical embolization. |
Q64966305 | What has changed in venous thromboembolism prophylaxis for hospitalized patients over recent decades: review article. |
Q54975780 | Why Do Patients Bleed? |
Q67567473 | Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? |
Q44217663 | Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial |
Q80175242 | [An update on thrombosis prophylaxis in orthopaedic and accident surgery] |
Q79968288 | [Antithrombotic drugs in urological surgery. Treatment interfering with haemostasis in urology?] |
Q73278001 | [Aspirin and venous thromboembolism: some indications, but no certitude] |
Q68016402 | [Benefits and risks of unfractionated heparin in orthopedic surgery] |
Q81323802 | [Factors affecting quality of care for elderly subjects undergoing surgery for hip fracture: review of the literature] |
Q79538402 | [Perioperative hemostasis management] |
Q73564383 | [Preventing and treating venous thrombosis in 1997] |
Q84201604 | [Prevention of venous thromboembolic disease in general surgery] |
Q73230110 | [Treatment of submasive pulmonary embolism with low-molecular-weight heparin] |
Q83743922 | [Update in pulmonary thromboembolic disease] |
Q82993855 | [Venous thromboembolic disease in general surgery] |
Search more.